Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.
Clinical trial NCT00421369 · COMPLETED
Trial details
- NCT number
- NCT00421369
- Sponsor
- Hadassah Medical Organization
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.